Postdoctoral Opportunities in Tumor Microenvironment/Immunology

Location
Portland, Oregon
Salary
We offer competitive recruitment packages.
Posted
April 22 2019
Position Type
Full Time
Organization Type
Academia

Postdoctoral Opportunities in Tumor Microenvironment/Immunology at Oregon Health & Science Univeristy

Laboratories within the Knight Cancer Institute at Oregon Health & Science University in beautiful Portland, OR have multiple openings for postdoctoral fellows.

Visit http://www.ohsu.edu/cdcb-postdoc for links to laboratories with openings. Please apply directly to laboratory principal investigators via email.

Sud Anand, PhD: Research projects on non-coding RNAs in host cells impacting solid tumor progression with emphasis on immune cells in the tumor microenvironment.

Lisa M Coussens, PhD: We are broadly interested in understanding signals controlling innate and adaptive leukocyte responses and activities in solid tumors with projects examining myeloid - T cell cross talk and mechanisms regulated by complement proteins as mediators of tumor progression and tumor immunity.

Alexey Danilov, M.D., PhD: Preclinical and translational research on elucidating novel targets within the ubiquitin-proteasome pathway and mechanism of action and resistance to transcriptional CDKs in B-cell malignancies.

Lara E. Davis, MD: Translational sarcoma research elucidating aspects of the osteosarcoma immune microenvironment and undefined kinase fusions and optimizing CDK4 inhibition to increase sarcoma sensitivity to chemotherapy.

Julia Maxson, PhD: Understanding how genetic alterations cooperate to drive leukemia, and leveraging that information to develop therapeutic strategies.

Gordon Mills, MD, PhD: Translational programs characterizing mechanisms of drug sensitivity and resistance in human tumors with broad array of wet bench and bioinformatics tools.

Amy Moran, PhD: Translational cancer immunotherapy projects evaluating cross talk between sex steroids and immune cell function, role of microbiome, and mechanisms of action of non-conventional of T & NK cell inhibitors.

Ferdinando Pucci, PhD: Humoral immune responses, cell-mediated immunity, and antigen-specific immune reactions to tumor-derived extracellular vesicles impacting malignancy with the goal of developing next generation cancer vaccines.

Rosalie Sears, PhD: Pancreatic cancer research projects focused on tumor heterogeneity, lineage plasticity, epigenetic regulation and mechanisms of therapeutic resistance using omic and image analysis of patient tumors, patient-derived and genetic mouse models.

Josh Walker, M.D., PhD: Tumor cell intrinsic and microenvironmental factors regulating T cell effector dysfunction in cancer, impacting efficacy of novel combinations of chemotherapy, radiotherapy, and immunotherapy in cancer utilizing preclinical models with defined tumor antigens and clinical samples.